Although most hospitals have taken extra steps to reduce Clostridium difficile infections, many say they see no difference in infection rates. Also this week: a novel lung cancer drug wins “breakthrough” status.
No Reward Seen for Extra Effort on C. Diff
Many hospitals that instituted new programs to reduce Clostridium difficile infections have not seen any improvement, according to a survey of infection control professionals.
With more than 1,000 members of the Association for Professionals in Infection Control and Epidemiology (APIC) responding, some 70% said their institutions had adopted special procedures directed at C. difficile since March 2010, but only 42% indicated that infection rates had actually declined.